Pharmacogenetics and mental disorders
DOI:
https://doi.org/10.19230/jonnpr.3596Abstract
-
Downloads
References
McCarthy AD, Kennedy JL, Middleton LT. Pharmacogenetics in drug development. Philos Trans R Soc Lond B Biol Sci. 2005;360:1579-1588.
Lesko LJ, Salerno RA, Spear BB, Anderson DC, Anderson T, Brazell C, et al. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: Report of the first FDA-PWG-PhRMA- Dru Safe Workshop. J Clin Pharmacol. 2003;43:342-358.
Butler MG. Pharmacogenetics and psychiatric care: A review and commentary. J Ment Health Clin Psychol. 2018; 2:17-24.
Pirmohamed M. Pharmacogenetics: past, present and future. Drug Discov Today. 2011;16: 852-861.
Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, et al. Efficacy of prospective pharmacogenetic testing in the treatment of major depression disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry. 2017;17:250.
Hamilton SP. The promise of psychiatric pharmacogenomics. Biol Psychiatry. 2015; 77:29-35.
Spadaler J, Tuson M, López-Ibor JM, López-Ibor F, López-Ibor MI. Pharmacogenetic testing of the guidance of Psychiatric treatment: A multicenter retrospective analysis. CNS Spectr. 2016;21:1-10.
Downloads
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
